Prediction factors of tolvaptan effectiveness in patients with refractory ascites complicated with hepatocellular carcinoma

OBJECTIVE: Tolvaptan (TVP) is an effective treatment for patients with cirrhotic ascites; however, studies have indicated that a sufficient effect is difficult to obtain in patients with hepatocellular carcinoma (HCC). This study evaluates the efficacy of TVP in patients with HCC with refractory asc...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, Michitaka, Ishikawa, Toru, Kojima, Yuichi, Azumi, Motoi, Nozawa, Yujiro, Sano, Tomoe, Iwanaga, Akito, Honma, Terasu, Yoshida, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2020
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734621/
https://www.ncbi.nlm.nih.gov/pubmed/33196517
http://dx.doi.org/10.1097/MEG.0000000000001985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734621/
https://www.ncbi.nlm.nih.gov/pubmed/33196517
http://dx.doi.org/10.1097/MEG.0000000000001985

Ejemplares similares